Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.41 |
| ▸ | HTR7 | P34969 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | PKLR | P30613 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18988725 | 0.86 | MCOLN3 (0.46) | MMP2PKMLMNAL3MBTL1ALDH1A1 | |
| SCHEMBL18988636 | 0.86 | HSD11B1 (0.43) | MMP2MAPTHSD11B1ALDH1A1 | |
| SCHEMBL18988595 | 0.82 | HSD11B1 (0.51) | MMP2CYP3A4CYP2C19PKMHSD11B1 | |
| SCHEMBL2185769 | 0.78 | CYP3A4 (0.48) | TRPA1MMP2CYP3A4CYP2C19PKM | |
| SCHEMBL2185773 | 0.78 | CYP3A4 (0.48) | TRPA1MMP2CYP3A4CYP2C19PKM | |
| SCHEMBL7118504 | 0.77 | MAPT (0.52) | TRPA1MMP2CYP3A4CYP2C19PKM | |
| SCHEMBL7118507 | 0.77 | MAPT (0.52) | TRPA1MMP2CYP3A4CYP2C19PKM | |
| SCHEMBL7127867 | 0.76 | CA1 (0.50) | TRPA1PKMHTR7L3MBTL1ALDH1A1 | |
| SCHEMBL7127875 | 0.76 | CA1 (0.50) | TRPA1PKMHTR7L3MBTL1ALDH1A1 | |
| SCHEMBL7116937 | 0.75 | CYP3A4 (0.51) | TRPA1CYP3A4CYP2C19HTR7LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10995043-B2 | Method for producing perfluoroalkylated compound | RIKEN (JP) | 2021-05-04 | — | — | US | disclosed |
| US-10995043-B2 | Method for producing perfluoroalkylated compound | RIKEN (JP) | 2021-05-04 | — | — | US | disclosed |
| US-20200277243-A1 | METHOD FOR PRODUCING PERFLUOROALKYLATED COMPOUND | RIKEN (JP) | 2020-09-03 | — | — | US | disclosed |
| US-20200277243-A1 | METHOD FOR PRODUCING PERFLUOROALKYLATED COMPOUND | RIKEN (JP) | 2020-09-03 | — | — | US | disclosed |
| EP-3392228-A1 | METHOD FOR PRODUCING PERFLUOROALKYLATED COMPOUND | RIKEN (JP) | 2018-10-24 | — | — | EP | disclosed |
| WO-2017104589-A1 | METHOD FOR PRODUCING PERFLUOROALKYLATED COMPOUND | 国立研究開発法人理化学研究所 | 2017-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10995043-B2 | Method for producing perfluoroalkylated compound | PAOX, PPOX, GPX4 | TRPA1 1661/4885MMP2 2346/4885CYP3A4 468/4885 |
| US-20200277243-A1 | METHOD FOR PRODUCING PERFLUOROALKYLATED COMPOUND | PAOX, PPOX, GPX4 | TRPA1 1661/4885MMP2 2346/4885CYP3A4 468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.